G-Irascens Silver
Natural health product licensed in Canada
- Licence holder
- Royal Academy of Nutrition Science
- NPN or DIN-HM
- 80089278
- Status
- Active licence
- Licence date
- 21 November 2018
- Revision date
- 13 June 2022
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 180 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycine max Source : Seed Coat Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 6,000 mg Potency : 25 % Cyanidin 3-O-glucoside | 200 mg | Not calculated |
| Vaccinium macrocarpon Source : Fruit Extract : Matériel brut sec Extraction ratio : 90:1 Dry plant equivalent : 4,500 mg | 50 mg | Not calculated |
| Chrome Source : Picolinate de chrome (III) | 30 mcg | 180 µg |
Non-medicinal ingredients
Microcrystalline cellulose, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(1) Source of/Provides antioxidants. (2) Provides support for healthy glucose metabolism. (3) Helps tomaintain normal blood glucose levels. (4) Helps to maintain the body's ability to metabolize nutrients. (5)Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. (6) Americanginseng is traditionally used in Herbal Medicine to help relieve nervousness (as mild sedative). (7)American ginseng is traditionally used in Herbal Medicine to help relieve nervous dyspepsia / to help digestion in cases of nervousness and/or stress. (8) Used in Herbal Medicine as an adaptogen to helpmaintain a healthy immune system.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
(1) Consult a health care practitioner prior to use if you have a history of kidney stones. (2) Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are taking blood thinners or digoxin. (3) Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you have diabetes.
Source
Official Health Canada record, licence 80089278
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging